...
首页> 外文期刊>RSC Advances >Synthesis and biological evaluation of 2,2-dimethylbenzopyran derivatives as potent neuroprotection agents
【24h】

Synthesis and biological evaluation of 2,2-dimethylbenzopyran derivatives as potent neuroprotection agents

机译:2,2-二甲基吡喃衍生物作为有效神经保护剂的合成与生物学评价

获取原文
获取原文并翻译 | 示例

摘要

The development of novel neuroprotection agents is of great significance for the treatment of ischemic stroke. In this study, a series of compounds comprising 2,2-dimethylbenzopyran groups and cinnamic acid groups have been synthesized. Preferential combination principles and bioisostere that improved the neuroprotective effect of the compounds were identified for this series via biological activity assay in vitro. Meanwhile, a functional reversal group of the acrylamide amide resulted in the most active compounds. Among them, BN-07 significantly improved the morphology of neurons and obviously increased cell survival rate of primary neurons induced by oxygen glucose deprivation (OGD), superior to clinically used anti-ischemic stroke drug edaravone (Eda). Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents with more potency than Eda.
机译:新型神经保护剂的发展对于缺血性卒中的治疗具有重要意义。 在该研究中,已经合成了包含2,2-二甲基吡喃基团和肉桂酸基团的一系列化合物。 优惠的组合原理和生物isostere改善化合物的神经保护作用,通过体外通过生物活性测定鉴定了该系列的神经保护作用。 同时,丙烯酰胺酰胺的功能性反转基团导致最活性化合物。 其中,BN-07显着提高了神经元的形态,明显提高了氧葡萄糖剥夺(OGD)诱导的原发性神经元的细胞存活率,优于临床使用的抗缺血性卒中药物埃达拉夫酮(EDA)。 总体而言,我们的研究结果可以为新的抗缺血性卒中剂设计具有比EDA更多效力的替代策略。

著录项

  • 来源
    《RSC Advances 》 |2019年第5期| 共11页
  • 作者单位

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Dept Pharmacol Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Dept Pharmacol Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &

    Discovery Minist Educ Shenyang 110016 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号